Results 161 to 170 of about 245,105 (180)
Some of the next articles are maybe not open access.

Advances in Pharmacotherapy for Congenital Hyperinsulinism

Pediatric Drugs
Congenital hyperinsulinism (CHI) is a rare disorder causing persistent hypoglycaemia in infants due to excessive insulin secretion from pancreatic β-cells. It has genetic causes, primarily mutations in ATP-sensitive potassium channel genes (ABCC8, KCNJ11). CHI manifests in three forms-focal, diffuse, and atypical-distinguished by histology and genetics,
Nuria González-Llorens   +5 more
openaire   +3 more sources

Congenital hyperinsulinism due to mutations in

European Journal of Medical Genetics, 2020
Daphne Yau   +2 more
exaly  

Congenital Hyperinsulinism

2022
Jean-Baptiste Arnoux   +3 more
openaire   +1 more source

Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children

Journal of Pediatric Surgery, 2019
Lisa States   +2 more
exaly  

Clinical practice guidelines for congenital hyperinsulinism

Clinical Pediatric Endocrinology, 2017
Yutaka Kanamori   +2 more
exaly  

Congenital Hyperinsulinism

2009
Nils Peters   +199 more
openaire   +1 more source

Hepatitis in an infant treated with octreotide for congenital hyperinsulinism

Journal of Pediatric Endocrinology and Metabolism, 2013
Arieh Riskin, David Gillis
exaly  

Home - About - Disclaimer - Privacy